DE68921282D1 - Verfahren zur Herstellung von Human-Human-Hybridomen, die Herstellung monoklonaler bzw. polyklonaler Antikörper davon und therapeutische Verwendung davon. - Google Patents

Verfahren zur Herstellung von Human-Human-Hybridomen, die Herstellung monoklonaler bzw. polyklonaler Antikörper davon und therapeutische Verwendung davon.

Info

Publication number
DE68921282D1
DE68921282D1 DE68921282T DE68921282T DE68921282D1 DE 68921282 D1 DE68921282 D1 DE 68921282D1 DE 68921282 T DE68921282 T DE 68921282T DE 68921282 T DE68921282 T DE 68921282T DE 68921282 D1 DE68921282 D1 DE 68921282D1
Authority
DE
Germany
Prior art keywords
human
adenocarcinoma
carcinoma
hybridomas
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68921282T
Other languages
English (en)
Other versions
DE68921282T2 (de
Inventor
Kenneth Alonso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE68921282D1 publication Critical patent/DE68921282D1/de
Application granted granted Critical
Publication of DE68921282T2 publication Critical patent/DE68921282T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE68921282T 1988-09-23 1989-09-21 Verfahren zur Herstellung von Human-Human-Hybridomen, die Herstellung monoklonaler bzw. polyklonaler Antikörper davon und therapeutische Verwendung davon. Expired - Lifetime DE68921282T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24808288A 1988-09-23 1988-09-23

Publications (2)

Publication Number Publication Date
DE68921282D1 true DE68921282D1 (de) 1995-03-30
DE68921282T2 DE68921282T2 (de) 1995-06-22

Family

ID=22937601

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68921282T Expired - Lifetime DE68921282T2 (de) 1988-09-23 1989-09-21 Verfahren zur Herstellung von Human-Human-Hybridomen, die Herstellung monoklonaler bzw. polyklonaler Antikörper davon und therapeutische Verwendung davon.

Country Status (5)

Country Link
EP (1) EP0363703B1 (de)
JP (1) JP3212987B2 (de)
AT (1) ATE118814T1 (de)
CA (1) CA1341552C (de)
DE (1) DE68921282T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9022545D0 (en) 1990-10-17 1990-11-28 Wellcome Found Culture medium
CA2044421C (en) * 1990-11-27 2005-06-21 Thomas Hyatt Duffy Squamous cell carcinoma-like immunoreactive antigen from human female urine
US6593255B1 (en) 1998-03-03 2003-07-15 Ppg Industries Ohio, Inc. Impregnated glass fiber strands and products including the same
US6419981B1 (en) 1998-03-03 2002-07-16 Ppg Industries Ohio, Inc. Impregnated glass fiber strands and products including the same
US8105690B2 (en) 1998-03-03 2012-01-31 Ppg Industries Ohio, Inc Fiber product coated with particles to adjust the friction of the coating and the interfilament bonding
US8062746B2 (en) 2003-03-10 2011-11-22 Ppg Industries, Inc. Resin compatible yarn binder and uses thereof
DE10352977A1 (de) * 2003-11-13 2005-06-09 Müller-Hermelink, Hans Konrad, Prof. Dr. Muriner anti Idiotyp-Antikörpers oder anti Idiotyp-Antikörper aus der Ratte des humanen monoklonalen SC-1 Antikörpers
JP7102402B2 (ja) 2017-05-31 2022-07-19 日東電工株式会社 ポリテトラフルオロエチレン及び充填剤を含有する板状の複合材料

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE57107T1 (de) * 1981-01-28 1983-04-14 Coats Patons Plc, Glasgow, Scotland Verfahren zur herstellung von monoklonalen antikoerpern und zellen, faehig diese antikoerper herzustellen.
US4613576A (en) * 1983-03-09 1986-09-23 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cancer cells
US5106746A (en) * 1985-05-22 1992-04-21 E. I. Du Pont De Nemours And Company Process for the in vitro immunization of human splenocytes against tumor associated antigens

Also Published As

Publication number Publication date
CA1341552C (en) 2007-10-02
DE68921282T2 (de) 1995-06-22
JP3212987B2 (ja) 2001-09-25
ATE118814T1 (de) 1995-03-15
EP0363703A1 (de) 1990-04-18
JPH02195876A (ja) 1990-08-02
EP0363703B1 (de) 1995-02-22

Similar Documents

Publication Publication Date Title
ES8705975A1 (es) Un metodo de deteccion o localizacion de celulas de carcinoma humano.
ES2144440T3 (es) Anticuerpos monoclonales que reconocen el receptor del factor de crecimiento epidermico, celulas y metodos para su produccion y compuestos que los contienen.
ES2080717T3 (es) Hibridomas productores de anticuerpos monoclonales para nuevos epitopos de mucina.
NZ210867A (en) Tumour-specific monoclonal antibodies, production thereof and use
FI963393A (fi) Syöpäolosuhteiden määritys MAGE-geeni-ilmennyksellä
DE3686313D1 (de) Anti-immuntoxine gegen menschlichen eierstockkrebs und verfahren zu deren verwendung.
DE68921282D1 (de) Verfahren zur Herstellung von Human-Human-Hybridomen, die Herstellung monoklonaler bzw. polyklonaler Antikörper davon und therapeutische Verwendung davon.
MX9705349A (es) Anticuerpo monoclonal 1a7 y su uso para el tratamiento de melanona y carcinoma de celulas pequeñas.
DE69434097D1 (de) Apoptose induzierender monoklonaler antikörper
GB2086937B (en) Production of human monoclonal antibodies by human hybridomas
DE3586216D1 (de) Brusttumorassoziiertes antigen und monoklonale antikoerper dazu.
DE3583265D1 (de) Tumortherapeutikum und verfahren zu seiner herstellung.
FI861692A0 (fi) En ny tumoerassocierad antigen.
EP0273453A3 (de) Hybridoma-Zellinien und monoklonale Antikörper gegen Angiotensin-II
DE3580524D1 (de) Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen.
EP0278160A3 (de) Menschliche monoklonale Antikörper gegen Krebs, Hybridoma-Zellinien, die sie herstellen und ihre Anwendungen
TWI265811B (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
IT8220621A0 (it) Metodo per il trattamento della metastasi e della crescita di cellule tumorali.
IL60664A0 (en) Monoclonal antibodies and assay for the detection of breast cancer
IL67944A0 (en) Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition